19
Jun

Tekmira’s in-development treatment for Ebola virus failed to move the needle in a midstage trial, leading the drugmaker to halt the study and sending its share value downward.

…read more

Source: Tekmira’s Ebola drug comes up short in Phase II

    

0 No comments